
Refeyn
Accelerating discovery and revolutionizing single-molecule bioanalytics
Oxford, United Kingdom · Founded 2018
- Headquarters
- Oxford
- Employees
- 51–200
- Founded
- 2018
- Business Model
- B2B
- Website
- refeyn.com
About
Refeyn is an Oxford University spinout founded in 2018 that develops and commercializes mass photometry instruments for single-molecule bioanalysis. Its instruments enable researchers to rapidly measure the mass of individual biomolecules — including proteins, antibodies, nucleic acids, and viral vectors such as AAVs — in their native solution state without labels. Refeyn's product portfolio includes the TwoMP, MyMassMP, SamuxMP, and KaritroMP mass photometers, serving pharmaceutical, biotech, and academic research customers globally in drug development, structural biology, and cell and gene therapy quality control.
Summary
Refeyn is a Biotech company based in Oxford, United Kingdom, founded in 2018.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...

Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/refeyn"><img src="https://indexed.vc/api/badge/company/refeyn" alt="Refeyn on Indexed.vc" width="260" height="76" /></a>